Transcutaneous Auricular Vagus Nerve Stimulation Prevents Postoperative Delirium in Elderly Patients

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorBeijing Tiantan Hospital

About this trial

According to the 3D-CAM scale, evaluate the incidence of Postoperative Delirium within 5 days after surgery in elderly patients receiving taVNS.The results are expected to provide evidence of the safety and efficacy of perioperative prophylactic use of taVNS in the clinical application of improving postoperative brain health in elderly patients, as well as theoretical and practical basis for subsequent studies or clinical applications.

Eligibility criteria

Qualifiers

Age≥65 years

Expected operation time≥ 2 hours

Postoperative hospital stay≥ 4 days

Sign the informed consent form

Disqualifiers

Neurosurgery or cardiac surgery

Emergency surgery within 6 hours of admission

End-stage disease with an expected survival of < 3 months

Preoperative severe cognitive dysfunction affected perioperative cognitive function assessment

Trial design

Treatments tested in this trial

  • transauricular auricular vagus nerve stimulation

Treatment groups

1,776 Participants
are divided into 2 treatment groups

Sponsors and collaborators